1 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 1, Not yet recruiting 1, Recruiting 1, Terminated 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Skin Squamous Cell Carcinoma: new trials by email Literature Review of Skin Squamous Cell Carcinoma trials Research Report on Skin Squamous Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NIFR Image-guided Surgery for Malignant Soft Tissue Tumor With Low-dose SWIG Technique ICG administration - Dermatofibrosarcoma Protuberans (DFSP), Skin Squamous Cell Carcinoma | Phase 1 | Not yet recruiting | The Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College | 592 | 2024-10-30 | 2024-09-24 |
| Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors Cyclophosphamide, Neoantigen Peptide Vaccine, Pembrolizumab - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | Phase 1 / Phase 2 | Recruiting | Mayo Clinic | 138 | 2022-03-31 | 2026-08-20 |
| Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors Nanrilkefusp alfa, Pembrolizumab - Thyroid Cancer, Renal Cell Carcinoma | Phase 1 | Terminated | SOTIO Biotech AG | 115 | 2019-06-13 | 2026-03-27 |
| Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck Cancer Erlotinib Hydrochloride, Laboratory Biomarker Analysis - Recurrent Head and Neck Carcinoma, Recurrent Salivary Gland Carcinoma | Phase 1 | Completed | M.D. Anderson Cancer Center | 48 | 2009-08-05 | 2025-09-05 |
Carcinoma, Hepatocellular (2) · Carcinoma, Merkel Cell (2) · Carcinoma, Non-Small-Cell Lung (2) · Carcinoma, Renal Cell (2) · Melanoma (2) · Squamous Cell Carcinoma of Head and Neck (2) · Triple Negative Breast Neoplasms (2) · Uterine Cervical Neoplasms (2) · Anus Neoplasms (1) · Biliary Tract Neoplasms (1) · Carcinoma, Lobular (1) · Carcinoma, Transitional Cell (1) · Carcinosarcoma (1) · Dermatofibrosarcoma (1) · Endometrial Neoplasms (1)
Neoplasms (4) · Head and Neck Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Adenocarcinoma (2) · Breast Diseases (2) · Breast Neoplasms (2) · Bronchial Neoplasms (2) · Carcinoma (2) · Carcinoma, Bronchogenic (2) · Carcinoma, Neuroendocrine (2) · Carcinoma, Squamous Cell (2) · DNA Virus Infections (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2)
pembrolizumab (2) · Biopsy (1) · Colony-Stimulating Factors (1) · Cyclophosphamide (1) · Erlotinib Hydrochloride (1) · Immunoglobulin G (1) · Magnetic Resonance Spectroscopy (1) · Specimen Handling (1) · X-Rays (1) · sargramostim (1)
M.D. Anderson Cancer Center (1) · Mayo Clinic (1) · SOTIO Biotech AG (1) · The Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (1)
United States (3) · Czechia (1) · France (1) · Spain (1)
Stephane Champiat, Dr. (1) · Xiuning Le (1) · Yanyan Lou, MD, PhD (1)
2018 (1)